Related references
Note: Only part of the references are listed.The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer
Ryan Quiroz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Protein arginine methylation: from enigmatic functions to therapeutic targeting
Qin Wu et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling
Patrick J. Metz et al.
CELL REPORTS (2020)
Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)
Rachel L. Palte et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
A Chemical Probe for the Methyl Transferase PRMT5 with a Novel Binding Mode
Vineet Pande et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors
Hong Lin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors
Hong Lin et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?
James Jarrold et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation
Jia Yi Fong et al.
CANCER CELL (2019)
Preparation of 4′-Spirocyclobutyl Nucleoside Analogues as Novel and Versatile Adenosine Scaffolds
Jonas Verhoeven et al.
CHEMISTRY-A EUROPEAN JOURNAL (2019)
PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia
Aliaksandra Radzisheuskaya et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
A patent review of arginine methyltransferase inhibitors (2010-2018)
Xiao Li et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth
Shikui Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML
S. Kaushik et al.
LEUKEMIA (2018)
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity
Zahid Q. Bonday et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types
Michael Seiler et al.
CELL REPORTS (2018)
PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes
Pierre-Jacques Hamard et al.
CELL REPORTS (2018)
Aberrant RNA Splicing in Cancer and Drug Resistance
Bi-Dar Wang et al.
CANCERS (2018)
PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination
Thomas L. Clarke et al.
MOLECULAR CELL (2017)
Arginine Methylation: The Coming of Age
Romeo S. Blanc et al.
MOLECULAR CELL (2017)
Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma
Christian J. Braun et al.
CANCER CELL (2017)
The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation
S. S. Tarighat et al.
LEUKEMIA (2016)
JQ1, an inhibitor of the epigenetic reader BRD4, suppresses the bidirectional MYC-AP4 axis via multiple mechanisms
Sung Kyung Choi et al.
ONCOLOGY REPORTS (2016)
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666
Kenneth W. Duncan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5
Huan-Tian Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins (vol 22, pg 672, 2016)
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Splicing-factor alterations in cancers
Olga Anczukow et al.
RNA (2016)
The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation
Wei Du et al.
ONCOTARGET (2016)
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
Katya Marjon et al.
CELL REPORTS (2016)
The oxygenase Jmjd6-a case study in conflicting assignments
Angelika Boettger et al.
BIOCHEMICAL JOURNAL (2015)
CETSA: a target engagement assay with potential to transform drug discovery
Annika Jenmalm Jensen et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Histone H2A and H4 N-terminal Tails Are Positioned by the MEP50 WD Repeat Protein for Efficient Methylation by the PRMT5 Arginine Methyltransferase
Emmanuel S. Burgos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2
Andrea Hadjikyriacou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis
Fan Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre et al.
NATURE CHEMICAL BIOLOGY (2015)
Discovery of a Dual PRMT5-PRMT7 Inhibitor
David Smil et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski et al.
SCIENCE (2014)
Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery
Marco Bezzi et al.
GENES & DEVELOPMENT (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Crystal structure of the human PRMT5:MEP50 complex
Stephen Antonysamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
RioK1, a New Interactor of Protein Arginine Methyltransferase 5 (PRMT5), Competes with pICln for Binding and Modulates PRMT5 Complex Composition and Substrate Specificity
Gernot Guderian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Arginine methylation mediated by the Arabidopsis homolog of PRMT5 is essential for proper pre-mRNA splicing
Xian Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Proteomics strategy for quantitative protein interaction profiling in cell extracts
Kirti Sharma et al.
NATURE METHODS (2009)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs
G Meister et al.
EMBO JOURNAL (2002)
Share Paper
